% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Dagher:868033,
      author       = {Dagher, Alain and Palomero-Gallagher, Nicola},
      title        = {{M}apping dopamine with positron emission tomography: {A}
                      note of caution},
      journal      = {NeuroImage},
      volume       = {207},
      issn         = {1053-8119},
      address      = {Orlando, Fla.},
      publisher    = {Academic Press},
      reportid     = {FZJ-2019-06626},
      pages        = {116203 -},
      year         = {2020},
      abstract     = {Positron emission tomography (PET) imaging is uniquely
                      suited to measuring neurotransmitter signaling in the human
                      brain. PET tracers for neurotransmitter studies are ligands
                      of the receptor or enzyme of interest labelled with positron
                      emitting isotopes, usually 11C of 18F. By far the most
                      frequent target of PET neurotransmitter imaging is dopamine,
                      and the most commonly used tracer is [11C]raclopride, an
                      antagonist of the dopamine D2 receptor (D2R), first
                      developed by researchers at the Karolinska Institute (Farde
                      et al., 1986).},
      cin          = {INM-1},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-1-20090406},
      pnm          = {571 - Connectivity and Activity (POF3-571)},
      pid          = {G:(DE-HGF)POF3-571},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:31539589},
      UT           = {WOS:000509662600032},
      doi          = {10.1016/j.neuroimage.2019.116203},
      url          = {https://juser.fz-juelich.de/record/868033},
}